Login
$TCMD
$26.37 -$0.44 (1.64%) Live

$TCMD SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G
09 Nov 2026 Form 4: Burke William W, Director

Sold 5,000 shares ($135K)

06 Nov 2026 Form 4: Kiewiet Stephen A., Chief Operating Officer

Received 6,438 shares as a grant or award

06 Nov 2026 Form 3: Kiewiet Stephen A., Chief Operating Officer

No securities owned

05 Nov 2026 Form 4: King Laura G., Director

Sold 4,800 shares ($120K)

03 Nov 2026 144
03 Nov 2026 FORM 10-Q/A
03 Nov 2026 FORM 10-Q/A
02 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition

MINNEAPOLIS, MN, November 2, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results ...

20 Aug 2026 144
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 Form 4: Dodd Sheri Louise, Director

Sold 10,978 shares ($323K)

10 Aug 2026 144
10 Aug 2026 10-Q
10 Aug 2026 8-K: Results of Operations and Financial Condition

MINNEAPOLIS, MN, August 10th, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results...

13 Jul 2026 8-K: Regulation FD Disclosure; Other Events

Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

01 Jun 2026 FORM SD

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support